Across TCGA pan-cancer cohorts, KANK1P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of KANK1P1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where KANK1P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types KANK1P1 is over-expressed in tumor, although a few such as KIRP and KIRC show the opposite, repressed pattern.

HNSC, KIRP, and THCA are the cancer types where KANK1P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KANK1P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	II,III,IV	+0.029	.020	6	view →
KIRP	Male	All	−0.040	.024	2	view →
THCA	All	All	+0.020	.002	2	view →
KIRC	All	IV	−0.013	.018	2	view →
LUAD	All	All	+0.015	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

Exploration

Same gene, other analysis: KANK1P1 RNA expression & survival · all KANK1P1 data types